Comparative Analysis of International Databases of Adverse Drug Reactions

Comparative Analysis of International Databases of Adverse Drug Reactions

In 1968 the World Health Organisation initiated the development of an international programme for collection of data from the maximum number of sources about potential adverse effects of medicines. In order to implement this programme, a number of databases were created, such as the global database...

Full description

Bibliographic Details
Main Authors:	A. S. Kazakov, M. A. Darmostukova, T. M. Bukatina, N. Yu. Velts, R. N. Alyautdin
Format:	Article
Language:	Russian
Published:	Ministry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» 2020-09-01
Series:	Безопасность и риск фармакотерапии
Subjects:	database pharmacovigilance vigibase eudravigilance signal adverse reactions drug safety signal processing
Online Access:	https://www.risksafety.ru/jour/article/view/182

Similar Items

Major Aspects of Detection and Monitoring of Adverse Reactions Associated with Cephalosporin Antibiotic Treatment
by: E. Yu. Demchenkova, et al.
Published: (2021-03-01)

Computerized systems and databases for pharmacovigilance in Russia
by: B. K. Romanov, et al.
Published: (2024-12-01)

International Drug Safety Monitoring
by: A. S. Kazakov, et al.
Published: (2019-09-01)

Suspected cutaneous adverse drug reactions reported with traditional medicines: analysis of data for United Nations Asia region from WHO VigiBase
by: Manish J. Barvaliya, et al.
Published: (2023-05-01)

Indirect and Direct 65+ Patient Reporting of Non-Steroidal Anti-Inflammatory Drug-Induced Adverse Drug Reactions as a Source of Information on Polypharmacy and Polypharmacy-Related Risk
by: Kamila Sienkiewicz, et al.
Published: (2023-08-01)

Reporting Antimicrobial-Related Adverse Drug Events in Jordan: An Analysis from the VigiBase Database
by: Nizar Mahmoud Mhaidat, et al.
Published: (2023-03-01)

Adverse Reactions to the Orphan Drug Cerliponase Alfa in the Treatment of Neurolipofuscinosis Type 2 (CLN2)
by: Ilaria Ammendolia, et al.
Published: (2024-11-01)

Adverse Reactions to Evolocumab: Analysis of Real-World Data from EudraVigilance
by: Fabrizio Calapai, et al.
Published: (2024-03-01)

The Adverse Drug Reactions Registered During the Postmarketing Period
by: E. V. Shubnikova, et al.
Published: (2019-03-01)

Comparative Study of Adverse Drug Reactions Associated with Filgrastim and Pegfilgrastim Using the EudraVigilance Database
by: Shruti Rastogi, et al.
Published: (2022-02-01)

Prevalence of Cutaneous Adverse Drug Reactions According to Iraqi Pharmacovigilance Center; A retrospective study for 11 years (2010-2021)
by: Ahmed Sami, et al.
Published: (2024-07-01)

Report of the Russian database on adverse drug reactions for COVID-19-related drugs with a focus on favipiravir
by: Mishinova S.A., et al.
Published: (2023-03-01)

Safety profile of tirzepatide: A real-world pharmacovigilance analysis of EudraVigilance database
by: Atul Khurana, et al.
Published: (2024-11-01)

Seriousness and outcomes of reported adverse drug reactions in old and new antiseizure medications: a pharmacovigilance study using EudraVigilance database
by: Michael Magdy Fahmy Girgis, et al.
Published: (2024-07-01)

Signal Detection of Adverse Drug Reactions of Cephalosporins Using Data from a National Pharmacovigilance Database
by: Jung-Yoon Choi, et al.
Published: (2021-05-01)

Analysis of Hepatobiliary Disorder Reports Associated With the Use of Herbal Medicines in the Global Suspected ADR Database Vigibase
by: Florence van Hunsel, et al.
Published: (2019-11-01)

Drug Safety for Children — International Monitoring Data for 50 Years
by: B. K. Romanov, et al.
Published: (2019-06-01)

Safety Profile of Medicines Used for the Treatment of Drug-Resistant Tuberculosis: A Descriptive Study Based on the WHO Database (VigiBase<sup>®</sup>)
by: Alemayehu Lelisa Duga, et al.
Published: (2023-04-01)

Descriptive Analysis of Adverse Drug Reactions Reports of the Most Consumed Antibiotics in Portugal, Prescribed for Upper Airway Infections
by: Joana Ferreira, et al.
Published: (2022-04-01)

Side effects reported by European consumers for medications for erectile dysfunction
by: Lise Aagaard, et al.
Published: (2013-01-01)

Knowledge and Perceptions of Adverse Events Following Immunization among Healthcare Professionals in Africa: A Case Study from Ghana
by: Peter Yamoah, et al.
Published: (2019-03-01)

Exploring the dark side of diagnostic dyes with a focus on Indocyanine green’s adverse reactions
by: Yan Jiao, et al.
Published: (2024-12-01)

Fluoroquinolone antibiotics: safety of use by the example of ciprofloxacin
by: N. V. Molchan, et al.
Published: (2019-06-01)

Retrospective analysis of neoplasms in patients using angiotensin receptor blockers
by: Arvind Kumar Sharma, et al.
Published: (2024-07-01)

Side effects of antineoplastic and immunomodulating medications reported by European consumers
by: Lise Aagaard, et al.
Published: (2013-01-01)

Hepatobiliary Adverse Reactions during Treatment with Cladribine: Analysis of Data from the European Spontaneous Reporting System
by: Elena Mirabela Velișcu, et al.
Published: (2023-07-01)

SIGNAL AS A TOOL OF THE PHARMACOVIGILANCE
by: E. O. Zhuravleva, et al.
Published: (2018-06-01)

Comparing epidemiological methods in detecting drug safety signal in IRAN
by: G Shalviri, et al.
Published: (2005-12-01)

Adverse Reactions of Drugs Containing Valeriana and Corvalol: Analysis of Spontaneous Reporting
by: S. L. Morokhina, et al.
Published: (2018-12-01)

Levofloxacin: Analysis of Information on Adverse Reactions from Russian Spontaneous Report Database
by: S. K. Zyryanov, et al.
Published: (2020-05-01)

Unveiling the Hidden Risks: An Update Decade-Long Analysis of Abraxane-Related Adverse Events from the FAERS Database
by: Zhao YC, et al.
Published: (2024-11-01)

Unknown adverse drug reactions from spontaneous reports in a hospital setting: characterization, follow-up, and contribution to the pharmacovigilance system
by: Francesca Filippi-Arriaga, et al.
Published: (2023-07-01)

Smartphone-based mobile applications for adverse drug reactions reporting: global status and country experience
by: Ayako Fukushima, et al.
Published: (2022-05-01)

Pharmacovigilance: pharmacists’ perspective on spontaneous adverse drug reaction reporting
by: Hadi MA, et al.
Published: (2017-03-01)

Capillary leak syndrome following COVID-19 vaccination: Data from the European pharmacovigilance database Eudravigilance
by: Rosanna Ruggiero, et al.
Published: (2022-09-01)

Empowering Patient Safety: Assessment of Adverse Drug Reaction Knowledge and Practice Among Pharmacy Professionals
by: Josipa Bukić, et al.
Published: (2024-12-01)

Second-Generation Cephalosporins-Associated Drug-Induced Liver Disease: A Study in VigiBase with a Focus on the Elderly
by: Mariana Sipos, et al.
Published: (2021-05-01)

Identification and Evaluation of Safety Signals of Drugs Currently under Development Using a Limited Data Set
by: B. K. Romanov, et al.
Published: (2019-12-01)

Identifying and Characterizing Serious Adverse Drug Reactions Associated With Drug-Drug Interactions in a Spontaneous Reporting Database
by: Lara Magro, et al.
Published: (2021-01-01)

Safety Monitoring of mRNA COVID-19 Vaccines in Children Aged 5 to 11 Years by Using EudraVigilance Pharmacovigilance Database: The CoVaxChild Study
by: Alessia Zinzi, et al.
Published: (2023-02-01)